{"ok":true,"data":[{"type":"bse_announcement","source":"bse_filing","text":"Announcement under Regulation 30 (LODR)-Investor Presentation","date":"2026-09-22"},{"type":"nse_announcement","source":"regulatory","text":"Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation","date":"2026-09-23"},{"type":"bse_announcement","source":"bse_filing","text":"Closure of Trading Window","date":"2026-09-25"},{"type":"bse_announcement","source":"bse_filing","text":"Receipt Of Approval Of The Shareholders For Reclassification Of Shareholder Category","date":"2026-09-26"},{"type":"nse_announcement","source":"regulatory","text":"Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","date":"2026-09-26"},{"type":"nse_announcement","source":"regulatory","text":"Receipt of approval of the shareholders for reclassification of shareholder category","date":"2026-09-27"},{"type":"bse_announcement","source":"bse_filing","text":"Completion And Result Of Postal Ballot Dated 25 August 2026","date":"2026-09-28"},{"type":"bse_announcement","source":"bse_filing","text":"Announcement under Regulation 30 (LODR)-Press Release / Media Release","date":"2026-09-28"},{"type":"nse_announcement","source":"regulatory","text":"Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release for Lerodalcibep licensing agreement.","date":"2026-09-28"},{"type":"bse_announcement","source":"bse_filing","text":"ESG Overview For FY 2025-26","date":"2026-09-29"},{"type":"nse_announcement","source":"regulatory","text":"Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Completion and Result of Postal Ballot dated 25 August 2026'.","date":"2026-09-29"},{"type":"nse_announcement","source":"regulatory","text":"Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'ESG Overview for FY 2025-26'.","date":"2026-09-30"}]}